UniSa - IRIS Institutional Research Information System

BARONE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 30.113
NA - Nord America 19.312
EU - Europa 6.642
SA - Sud America 1.786
OC - Oceania 208
AF - Africa 121
Continente sconosciuto - Info sul continente non disponibili 18
Totale 58.200
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 23.088
US - Stati Uniti d'America 18.980
SG - Singapore 2.837
CN - Cina 2.042
BR - Brasile 1.508
IT - Italia 1.451
UA - Ucraina 1.420
RU - Federazione Russa 920
VN - Vietnam 827
DE - Germania 775
IE - Irlanda 633
KR - Corea 450
TR - Turchia 402
SE - Svezia 347
FI - Finlandia 314
GB - Regno Unito 239
CA - Canada 197
EE - Estonia 146
IN - India 129
NZ - Nuova Zelanda 104
AR - Argentina 102
AU - Australia 98
MX - Messico 76
PL - Polonia 61
NL - Olanda 58
EC - Ecuador 55
BD - Bangladesh 54
AT - Austria 53
FR - Francia 51
JP - Giappone 46
ID - Indonesia 41
ES - Italia 40
IQ - Iraq 34
CZ - Repubblica Ceca 30
ZA - Sudafrica 30
CO - Colombia 27
MA - Marocco 23
PK - Pakistan 22
PY - Paraguay 22
UZ - Uzbekistan 22
IL - Israele 20
VE - Venezuela 20
CL - Cile 19
EU - Europa 16
AE - Emirati Arabi Uniti 15
DO - Repubblica Dominicana 14
PE - Perù 14
BE - Belgio 11
LT - Lituania 11
UY - Uruguay 11
EG - Egitto 10
BG - Bulgaria 9
KE - Kenya 9
AL - Albania 8
JM - Giamaica 8
SA - Arabia Saudita 8
AZ - Azerbaigian 7
ET - Etiopia 7
IR - Iran 7
NP - Nepal 7
TN - Tunisia 7
BO - Bolivia 6
CH - Svizzera 6
DK - Danimarca 6
DZ - Algeria 6
BA - Bosnia-Erzegovina 5
CR - Costa Rica 5
GR - Grecia 5
JO - Giordania 5
RO - Romania 5
SV - El Salvador 5
BW - Botswana 4
BY - Bielorussia 4
KZ - Kazakistan 4
LU - Lussemburgo 4
ME - Montenegro 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
PR - Porto Rico 4
RS - Serbia 4
TW - Taiwan 4
BH - Bahrain 3
CI - Costa d'Avorio 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
MN - Mongolia 3
MY - Malesia 3
NI - Nicaragua 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SO - Somalia 3
TJ - Tagikistan 3
AO - Angola 2
BS - Bahamas 2
BZ - Belize 2
Totale 58.141
Salva come PNG Salva come JPEG
Città #
Hong Kong 23.069
Ann Arbor 4.156
Wilmington 2.250
Jacksonville 1.729
Princeton 1.634
Chandler 1.535
Dallas 1.119
Singapore 845
Houston 738
Woodbridge 616
Ashburn 597
Dublin 594
Dong Ket 459
Nanjing 399
Beijing 384
Andover 368
Izmir 364
Moscow 314
Boardman 298
Pellezzano 264
Düsseldorf 216
Mestre 203
Los Angeles 169
Naples 149
Tallinn 146
Norwalk 143
Ho Chi Minh City 140
Shenyang 134
São Paulo 132
Fairfield 131
Salerno 122
Hebei 121
Munich 121
Changsha 111
Nanchang 108
Dearborn 107
New York 94
Jiaxing 85
Hanoi 73
Rome 67
The Dalles 67
Redwood City 60
Tianjin 56
Nuremberg 54
Rio de Janeiro 53
San Diego 49
Brooklyn 48
Pune 48
Warsaw 48
Auckland 43
Montreal 43
Santa Clara 43
Columbus 42
Sydney 42
Milan 38
San Francisco 37
Seoul 37
Stockholm 37
Belo Horizonte 36
Tokyo 36
Council Bluffs 35
Turku 35
West Jordan 35
Amsterdam 33
Washington 33
Seattle 32
Cambridge 31
Brasília 30
Curitiba 30
Jinan 29
Boston 28
Casoria 28
Phoenix 28
Atlanta 27
London 27
Ottawa 27
Chicago 24
Porto Alegre 24
Chennai 23
Lappeenranta 23
Poplar 23
Denver 21
Fort Worth 21
Guangzhou 21
Guayaquil 21
Campinas 20
Toronto 20
Guarulhos 19
Springfield 19
Tashkent 19
Johannesburg 18
Venezia 18
Vienna 18
Ankara 17
Quito 17
Shanghai 17
Baghdad 16
Haiphong 16
Melbourne 16
Brno 15
Totale 46.175
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.166
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 961
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 926
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 914
Trial of Deferiprone in Parkinson's Disease 656
Sex Differences in Parkinson’s Disease: From Bench to Bedside 625
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 581
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 573
Cognitive impairment in nondemented Parkinson's disease. 562
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 552
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. 530
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease. 528
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 515
Gender differences in microRNA expression in levodopa-naive PD patients 513
A simulation tool to plan daily nurse requirements 504
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclearpalsy. 502
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 489
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 478
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. Apr 30;24(6):899-905.PMID: 19205072 455
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 437
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 436
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 428
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 427
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 412
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. 412
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 409
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 390
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 375
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 372
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 361
Neurotransmission in Parkinson's disease: beyond dopamine. 354
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 333
Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis 332
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 311
Bilateral facial palsy after COVID-19 vaccination 306
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 306
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 302
Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes 295
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial 290
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 287
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 284
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 281
Association study between the LINGO1 gene and Parkinson's disease in the Italian population 275
A novel phenotype in an Italian family with a rare progranulin mutation 272
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 259
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 258
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 256
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 248
Trial of Cinpanemab in Early Parkinson's Disease 247
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 243
Classifying Different Stages of Parkinson’s Disease Through Random Forests 234
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 233
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 228
Metabolomics in Parkinson's disease 219
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 212
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 199
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 197
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 195
Personality in Parkinson's disease: Clinical, behavioural and cognitive correlates 193
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 186
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 182
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 175
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 172
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 169
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 166
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 165
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 162
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 161
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 158
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 151
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 147
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 146
Accuracy of clinical diagnostic criteria for Friedreich'sataxia. 146
Adherence to anti-Parkinson drug therapy in the ?REASON? sample of Italian patients with Parkinson?s disease: the linguistic validation of the Italian version of the ?Morisky Medical Adherence scale-8 items? 145
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 142
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 141
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 139
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 138
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 138
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 138
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 135
Affective theory of mind in patients with Parkinson's disease: comment 131
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 130
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 130
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 128
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 128
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 128
The natural history of multiple system atrophy: A prospective European cohort study 125
Increased bilirubin levels in de novo Parkinson's disease 124
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 124
Normative data for the Montreal Cognitive Assessment in an Italian population sample 123
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 121
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 121
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. 120
The PRIAMO study: background, methods and recruitment. Apr;29(2):61-5. .PMID: 18483702 120
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 120
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 119
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 119
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 118
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients 118
Totale 29.887
Salva come PNG Salva come JPEG
Categoria #
all - tutte 184.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.330
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.093 0 0 0 0 363 136 344 19 305 22 341 563
2021/20222.615 14 4 14 25 23 16 40 112 405 368 356 1.238
2022/20234.002 472 174 97 355 656 927 20 382 628 18 187 86
2023/20242.059 159 310 110 162 100 197 86 131 71 138 175 420
2024/20256.305 260 60 145 369 216 669 731 686 911 692 741 825
2025/202628.243 4.870 11.165 9.973 1.342 893 0 0 0 0 0 0 0
Totale 59.278